眼部保健補充劑市場規模、佔有率、成長分析（按成分類型、適應症、配方、分銷管道和地區）—2025-2032 年行業預測

2023 年眼部保健補充劑市場規模價值 25 億美元，預計將從 2024 年的 26.7 億美元成長到 2032 年的 44.8 億美元，預測期內（2025-2032 年）的複合年成長率為 6.7%。

由於視力障礙和近視的盛行率不斷上升，尤其是在 COVID-19 疫情期間螢幕時間的增加，眼部保健補充劑市場正在經歷顯著成長。白內障、青光眼和老齡化黃斑部病變（AMD）等疾病正變得越來越普遍，尤其是在老化人口數位原民代千禧世代。特別是，根據世界衛生組織（WHO）的報告，全球約有22億人患有視力問題，中低收入國家受到的影響尤其嚴重。隨著已開發國家消費支出的成長，對葉黃素、玉米黃質和其他補充劑的需求不斷成長，進一步推動了市場的擴張。由於轉向線上銷售管道，眼部補充劑的電子商務銷售額最近成長了近48.3％，鞏固了美國市場的積極成長軌跡。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術分析

眼部保健補充劑市場規模（按成分類型和複合年成長率） (2025-2032)

• 市場概覽
• 葉黃素和玉米黃質
• 抗氧化劑
• Omega-3脂肪酸
• Coenzyme Q10
• 黃酮類化合物
• 硫辛酸
• 蝦青素
• 其他

眼部保健補充劑市場規模（按適應症和複合年成長率） (2025-2032)

• 市場概覽
• 老齡化黃斑部病變（AMD）
• 白內障
• 乾眼症
• 發炎
• 其他

眼部保健補充劑市場規模（按配方和複合年成長率） (2025-2032)

• 市場概覽
• 藥片
• 膠囊
• 粉末
• 軟膠囊
• 液體
• 其他

眼部保健品市場規模（依通路及複合年成長率）(2025-2032)

• 市場概覽
• 醫院藥房
• 零售藥局
• 大賣場和超級市場
• 電子商務

眼部保健品市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Santen Pharmaceutical（Japan）
• Rohto Pharmaceutical（Japan）
• Dompe Farmaceutici（Italy）
• Vianex SA（Greece）
• Abbott Laboratories（USA）
• Bausch+Lomb（USA）
• Alcon（Switzerland）
• Pfizer Inc.（USA）
• Novartis AG（Switzerland）
• Thea Pharma（France）
• Similasan AG（Switzerland）
• Jamieson Wellness（Canada）
• Nature's Way（USA）
• NOW Foods（USA）
• Nature's Bounty（USA）
• GNC Holdings（USA）
• Herbalife Nutrition（USA）
• Amway（USA）
• Pharma Nord（Denmark）
• Solgar（USA）

結論和建議

Eye Health Supplements Market size was valued at USD 2.5 billion in 2023 and is poised to grow from USD 2.67 billion in 2024 to USD 4.48 billion by 2032, growing at a CAGR of 6.7% during the forecast period (2025-2032).

The eye health supplements market is experiencing significant growth driven by the increasing prevalence of vision impairment and myopia, particularly exacerbated by heightened screen time during the COVID-19 pandemic. Conditions such as cataracts, glaucoma, and age-related macular degeneration (AMD) are becoming more common, especially among the aging population and digital-native millennials. Notably, the World Health Organization reports that approximately 2.2 billion people globally struggle with vision issues, with a disproportionate impact in low to middle-income countries. Rising consumer spending in developed nations, alongside the growing demand for Lutein, Zeaxanthin, and other supplements, further propels market expansion. The shift towards online sales channels has significantly increased accessibility, with e-commerce sales of eye supplements up nearly 48.3% recently, reinforcing a positive growth trajectory for the U.S. eye health supplements market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Eye Health Supplements market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Eye Health Supplements Market Segments Analysis

Global Eye Health Supplements Market is segmented by Ingredient Type, Indication, Formulation, Distribution Channel and region. Based on Ingredient Type, the market is segmented into Lutein & Zeaxanthin, Antioxidants, Omega-3 Fatty Acids, Coenzyme Q10, Flavonoids, Alpha-Lipoic Acid, Astaxanthin and Others. Based on Indication, the market is segmented into Age-related Macular Degeneration (AMD), Cataract, Dry Eye Syndrome, Inflammation and Others. Based on Formulation, the market is segmented into Tablets, Capsules, Powder, Softgels, Liquid and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Hypermarkets & Supermarkets and E-Commerce. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Eye Health Supplements Market

The increasing occurrence of eye-related conditions, including age-related macular degeneration (AMD), cataracts, and dry eye syndrome, is fueling the demand for eye health supplements. With a rapidly aging global population, the prevalence of these disorders is anticipated to grow, leading to an expanding market for supplements designed to promote and maintain eye health. As individuals become more aware of the importance of eye care, there is a greater inclination towards preventative measures, further driving the need for effective eye health supplements. This trend highlights the significant opportunity within the market as consumers seek to protect their vision and overall ocular well-being.

Restraints in the Eye Health Supplements Market

The Eye Health Supplements market faces a significant restraint due to the limited scientific evidence surrounding their effectiveness and long-term consequences. Although anecdotal accounts and some preliminary research suggest potential benefits, the absence of comprehensive clinical studies and consistent research methodologies poses a challenge. This inadequacy can undermine consumer trust and willingness to embrace these products, as many individuals may hesitate to invest in supplements when the scientific backing is not sufficiently robust. Consequently, the market may struggle to gain traction as consumers seek more credible information before making purchasing decisions related to eye health supplements.

Market Trends of the Eye Health Supplements Market

The Eye Health Supplements market is witnessing a significant trend driven by increasing consumer awareness regarding ocular wellness and the prevention of age-related conditions like macular degeneration and cataracts. As more individuals embrace proactive health management, the demand for eye health supplements is surging, with consumers incorporating these products into their daily wellness routines to support optimal vision and overall eye function. This trend is further fueled by the proliferation of information on the benefits of nutrients like lutein, zeaxanthin, and omega-3 fatty acids, positioning eye health supplements as essential components of holistic health strategies in an increasingly health-conscious market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Eye Health Supplements Market Size by Ingredient Type & CAGR (2025-2032)

• Market Overview
• Lutein & Zeaxanthin
• Antioxidants
• Omega-3 Fatty Acids
• Coenzyme Q10
• Flavonoids
• Alpha-Lipoic Acid
• Astaxanthin
• Others

Global Eye Health Supplements Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Age-related Macular Degeneration (AMD)
• Cataract
• Dry Eye Syndrome
• Inflammation
• Others

Global Eye Health Supplements Market Size by Formulation & CAGR (2025-2032)

• Market Overview
• Tablets
• Capsules
• Powder
• Softgels
• Liquid
• Others

Global Eye Health Supplements Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy
• Hypermarkets & Supermarkets
• E-Commerce

Global Eye Health Supplements Market Size & CAGR (2025-2032)

• North America (Ingredient Type, Indication, Formulation, Distribution Channel)
  • US
  • Canada
• Europe (Ingredient Type, Indication, Formulation, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Ingredient Type, Indication, Formulation, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Ingredient Type, Indication, Formulation, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Ingredient Type, Indication, Formulation, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Santen Pharmaceutical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rohto Pharmaceutical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dompe Farmaceutici (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vianex S.A. (Greece)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch + Lomb (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcon (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thea Pharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Similasan AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jamieson Wellness (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nature's Way (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NOW Foods (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nature's Bounty (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GNC Holdings (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Herbalife Nutrition (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amway (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharma Nord (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solgar (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations